MediPal Holdings Corporation
MEPDF · OTC
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Revenue | $3,671,328 | $3,558,732 | $3,360,008 | $3,290,921 |
| % Growth | 3.2% | 5.9% | 2.1% | – |
| Cost of Goods Sold | $3,415,569 | $3,312,077 | $3,135,703 | $3,073,476 |
| Gross Profit | $255,758 | $246,655 | $224,305 | $217,445 |
| % Margin | 7% | 6.9% | 6.7% | 6.6% |
| R&D Expenses | $0 | $0 | $103 | $108 |
| G&A Expenses | $0 | $165,203 | $144,338 | $140,870 |
| SG&A Expenses | $23,593 | $185,677 | $163,143 | $159,487 |
| Sales & Mktg Exp. | $23,593 | $20,474 | $18,805 | $18,617 |
| Other Operating Expenses | $176,557 | $13,648 | $12,082 | $12,223 |
| Operating Expenses | $200,150 | $199,325 | $175,328 | $171,818 |
| Operating Income | $55,609 | $47,331 | $48,972 | $45,624 |
| % Margin | 1.5% | 1.3% | 1.5% | 1.4% |
| Other Income/Exp. Net | $21,125 | $27,410 | $21,089 | $11,660 |
| Pre-Tax Income | $76,734 | $74,741 | $70,061 | $57,284 |
| Tax Expense | $25,203 | $22,973 | $21,738 | $18,087 |
| Net Income | $40,279 | $41,474 | $38,806 | $29,423 |
| % Margin | 1.1% | 1.2% | 1.2% | 0.9% |
| EPS | 193.2 | 195.83 | 184.82 | 140.13 |
| % Growth | -1.3% | 6% | 31.9% | – |
| EPS Diluted | 193.2 | 195.83 | 179.12 | 131.41 |
| Weighted Avg Shares Out | 208 | 212 | 210 | 210 |
| Weighted Avg Shares Out Dil | 208 | 212 | 216 | 223 |
| Supplemental Information | – | – | – | – |
| Interest Income | $50 | $29 | $101 | $177 |
| Interest Expense | $7 | $8 | $34 | $16 |
| Depreciation & Amortization | $18,417 | $17,982 | $14,648 | $14,338 |
| EBITDA | $95,158 | $65,313 | $63,622 | $59,963 |
| % Margin | 2.6% | 1.8% | 1.9% | 1.8% |